Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1980 1
1981 7
1982 5
1983 4
1984 4
1985 12
1986 6
1987 3
1988 7
1989 15
1990 9
1991 12
1992 18
1993 15
1994 24
1995 21
1996 23
1997 33
1998 35
1999 29
2000 48
2001 35
2002 49
2003 34
2004 33
2005 44
2006 33
2007 31
2008 34
2009 40
2010 39
2011 31
2012 34
2013 48
2014 27
2015 47
2016 36
2017 40
2018 33
2019 41
2020 50
2021 50
2022 37
2023 14

Text availability

Article attribute

Article type

Publication date

Search Results

1,096 results

Results by year

Filters applied: . Clear all
Page 1
Posttransplant Lymphoproliferative Disorder Following Kidney Transplantation: A Review.
Sprangers B, Riella LV, Dierickx D. Sprangers B, et al. Am J Kidney Dis. 2021 Aug;78(2):272-281. doi: 10.1053/j.ajkd.2021.01.015. Epub 2021 Mar 25. Am J Kidney Dis. 2021. PMID: 33774079 Review.
Given the number of kidney transplants performed, KTRs who experience PTLD outnumber other organ transplant recipients who experience PTLD. Epstein-Barr virus infection is one of the most important risk factors for PTLD, even though 40% of PTLD …
Given the number of kidney transplants performed, KTRs who experience PTLD outnumber other organ transplant recipients …
Post-transplant lymphoproliferative disorders.
Dharnidharka VR, Webster AC, Martinez OM, Preiksaitis JK, Leblond V, Choquet S. Dharnidharka VR, et al. Nat Rev Dis Primers. 2016 Jan 28;2:15088. doi: 10.1038/nrdp.2015.88. Nat Rev Dis Primers. 2016. PMID: 27189056 Review.
PTLDs show some similarities to classic lymphomas in the non-immunosuppressed general population. The oncogenic Epstein-Barr virus (EBV) is a key pathogenic driver in many early-onset cases, through multiple mechanisms. The incidence of PTLD varies with the t …
PTLDs show some similarities to classic lymphomas in the non-immunosuppressed general population. The oncogenic Epstein-Bar …
Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies.
Al-Mansour Z, Nelson BP, Evens AM. Al-Mansour Z, et al. Curr Hematol Malig Rep. 2013 Sep;8(3):173-83. doi: 10.1007/s11899-013-0162-5. Curr Hematol Malig Rep. 2013. PMID: 23737188 Free PMC article. Review.
Post-transplant lymphoproliferative diseases (PTLD) are heterogeneous lymphoid disorders ranging from indolent polyclonal proliferations to aggressive lymphomas that complicate solid organ or hematopoietic transplantation. ...Clinically, extra-nodal di …
Post-transplant lymphoproliferative diseases (PTLD) are heterogeneous lymphoid disorders ranging from indolent polyclonal proliferati …
Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation.
Prockop S, Doubrovina E, Suser S, Heller G, Barker J, Dahi P, Perales MA, Papadopoulos E, Sauter C, Castro-Malaspina H, Boulad F, Curran KJ, Giralt S, Gyurkocza B, Hsu KC, Jakubowski A, Hanash AM, Kernan NA, Kobos R, Koehne G, Landau H, Ponce D, Spitzer B, Young JW, Behr G, Dunphy M, Haque S, Teruya-Feldstein J, Arcila M, Moung C, Hsu S, Hasan A, O'Reilly RJ. Prockop S, et al. J Clin Invest. 2020 Feb 3;130(2):733-747. doi: 10.1172/JCI121127. J Clin Invest. 2020. PMID: 31689242 Free PMC article. Clinical Trial.
BACKGROUNDAdoptive transfer of donor-derived EBV-specific cytotoxic T-lymphocytes (EBV-CTLs) can eradicate EBV-associated lymphomas (EBV-PTLD) after transplantation of hematopoietic cell (HCT) or solid organ (SOT) but is unavailable for most patients.METHODSW …
BACKGROUNDAdoptive transfer of donor-derived EBV-specific cytotoxic T-lymphocytes (EBV-CTLs) can eradicate EBV-associated lymphomas ( …
Lymphoma: risk and response after solid organ transplant.
Jacobson CA, LaCasce AS. Jacobson CA, et al. Oncology (Williston Park). 2010 Sep;24(10):936-44. Oncology (Williston Park). 2010. PMID: 21138175 Free article. Review.
Post-transplant lymphoproliferative disorder (PTLD) is a common and serious complication of solid organ transplantation. ...Risk factors for the development of PTLD thus reflect loss or absence of EBV immunity; they include younger age and pre-transplant …
Post-transplant lymphoproliferative disorder (PTLD) is a common and serious complication of solid organ transplantation …
Immunodeficiency-associated lymphomas.
Tran H, Nourse J, Hall S, Green M, Griffiths L, Gandhi MK. Tran H, et al. Blood Rev. 2008 Sep;22(5):261-81. doi: 10.1016/j.blre.2008.03.009. Epub 2008 May 5. Blood Rev. 2008. PMID: 18456377 Review.
Acquired immunodeficiencies predominantly occur in the setting of infection with the Human Immunodeficiency Virus or arise following immunosuppressive therapy administered after organ transplantation. The rising incidence of HIV throughout the world and the dramatic …
Acquired immunodeficiencies predominantly occur in the setting of infection with the Human Immunodeficiency Virus or arise following immunos …
Belatacept.
[No authors listed] [No authors listed] Prescrire Int. 2012 Jul;21(129):173-6. Prescrire Int. 2012. PMID: 22852277
The risk was particularly high in patients receiving the high dose of belatacept, and in patients who were seronegative for Epstein-Barr virus. Overall, the risk of infections seems to be similar with belatacept and ciclosporin, but certain severe infections were mo …
The risk was particularly high in patients receiving the high dose of belatacept, and in patients who were seronegative for Epstein- …
B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
Dolcetti R. Dolcetti R. Autoimmun Rev. 2007 Dec;7(2):96-101. doi: 10.1016/j.autrev.2007.02.012. Epub 2007 Mar 26. Autoimmun Rev. 2007. PMID: 18035317 Review.
Epstein-Barr virus (EBV) is a ubiquitous human gamma-herpes virus that establishes a life-long asymptomatic infection in immunocompetent hosts by colonizing memory B lymphocytes and hijacking cellular signaling pathways that regulate antigen-dependent B-cell activat …
Epstein-Barr virus (EBV) is a ubiquitous human gamma-herpes virus that establishes a life-long asymptomatic infection in immun …
Epstein-Barr virus-associated T-cell lymphoma in solid organ transplant recipients.
Sivaraman P, Lye WC. Sivaraman P, et al. Biomed Pharmacother. 2001 Sep;55(7):366-8. doi: 10.1016/s0753-3322(01)00081-6. Biomed Pharmacother. 2001. PMID: 11669498 Review.
Post-transplantation lymphoproliferative diseases (PTLDs) are a heterogenous group of lymphoid proliferative disorders occurring in transplant patients. ...The first case of a T-cell, non-EBV-associated PTLD was first described in a renal allograft recipient in 1987 …
Post-transplantation lymphoproliferative diseases (PTLDs) are a heterogenous group of lymphoid proliferative disorders occurring in …
Post-transplant primary central nervous system lymphoma after Epstein-Barr virus cerebellitis.
Valencia-Sanchez C, Steenerson KK, Kelemen K, Orenstein R, Kusne S, Grill MF. Valencia-Sanchez C, et al. J Neurovirol. 2019 Apr;25(2):280-283. doi: 10.1007/s13365-018-0711-8. Epub 2019 Jan 3. J Neurovirol. 2019. PMID: 30607891
Post-transplantation lymphoproliferative disorder (PTLD) is a complication of solid organ and hematopoietic stem cell transplantation. Cases with isolated central nervous system (CNS) disease are rare. Epstein-Barr virus (EBV) plays a causative …
Post-transplantation lymphoproliferative disorder (PTLD) is a complication of solid organ and hematopoietic stem cell trans …
1,096 results